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PreviewsPCbiosynthesis are themselves unlikely to
be drug targets, due to the high level of
redundancy that characterizes different
pathways of de novo biosynthesis, it is
possible that proteins involved in lipid
exchange and transport across the PVM
and parasite membranes are potential
targets. It will be important to confirm
that human-infective species, such as
P. falciparum, P. vivax, and P. ovale, are
also dependent on PC uptake. Each of
these species exhibits subtle differences
in the time they take to develop in the liver
(e.g., 2 versus 7 days for P. berghei and
P. falciparum, respectively) and the final
parasite burdens reached. Significant dif-
ferences may also occur in the metabolic
activity of murine and human liver cells, all
of which could lead to species-specific dif-
ferences in metabolic demands. Another
intriguing possibility is that a decrease in
hepatocyte PC biosynthesis, possibly asa result of choline deficiency, could trigger
latency in some Plasmodium species.
Latency is thought to be associated with
the appearance ofmetabolically quiescent
liver stages and is a distinctive feature of
human infective P. vivax and P. ovale, re-
sulting in nonsymptomatic infections that
can reactivate longafter the initial infection.
Overall, these studies highlight the com-
plex metabolic interactions that underpin
all host-pathogen interactions and the
need to study themetabolismof both part-
ners together.REFERENCES
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Plant effector-triggered immunity is a robust cellular defense response activated by a family of intracellular
receptors. In this issue of Cell Host &Microbe, Wang et al. (2014) show that receptor-activated defense path-
ways utilize several core cell-cycle regulatory components to induce resistance and programmed cell death
against pathogens.Individual plant andmammalian cells have
the innate capacity to recognize interfer-
ence by pathogens and activate disease
resistance pathways. This provides a
crucial early defense mechanism against
infectiousmicrobesand isbroadly referred
to as innate immunity. Without innate
immunity, organisms rapidly succumb to
disease. On the flip side, misregulation
of cellular defenses can lead to autoimmu-
nity with potentially catastrophic conse-
quences for general health and growth
of the host. To enforce tight control,
structurally and functionally related nucle-otide-binding/leucine-rich-repeat recep-
tors (NLRs) have evolved independently
in each kingdom as ligand-dependent
molecular switches that sense pathogen-
driven perturbations in different parts of
thecell (Maekawaetal., 2011).NLRactiva-
tion mobilizes host antimicrobial defenses
and often induces programmed cell death
(PCD). Additional components of innate
immune signaling pathways have been
characterized in both systems, but the
processes by which activated NLRs con-
nectmolecularly to downstreampathways
to elicit timely and effective resistanceremain unclear (Maekawa et al., 2011;
Griebel et al., 2014). Also, operational
relationships between host defense and
cell death programs have not been fully
resolved. In plants, individual NLRs inter-
cept the activities of specific pathogen
effectors (virulence factors) that are deliv-
ered into host cells to disable basal
resistance pathways. Thus, recognition
by NLRs turns effector manipulation of
basal defenses into effector-triggered im-
munity (ETI).
The study by Wang et al. in this issue of
Cell Host & Microbe (Wang et al., 2014) isecember 10, 2014 ª2014 Elsevier Inc. 707
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ing of plant ETI signaling because it
fills some of the gaps between NLR
activation and the execution of disease
resistance. The authors provide compel-
ling genetic and molecular evidence that
the induction of pathways leading both
to immunity and PCD as part of ETI
is accomplished through modulation of
core regulators of the cell-cycle machin-
ery. Therefore, components of mitotic
cell-cycle progression that are highly con-
served across eukaryotes have been co-
opted for plant immunity.
Piecing together the plant cell cycle-im-
munity connection by Wang and col-
leagues (Wang et al., 2014) started with
a mutational screen for genetic sup-
pressors of an Arabidopsis autoimmunity
mutant, cpr5 (constitutive expressor of
pathogenesis-related genes 5), that dis-
plays constitutive PCD, enhanced basal
immunity against virulent pathogens,
and certain developmental abnormalities
indicative of defective cell division and
cell fate determination (Clarke et al.,
2001; Kirik et al., 2001). One cpr5 sup-
pressor mutation was mapped to a mem-
ber of the KIP-related protein (KRP) family
of cyclin-dependent kinase inhibitor (CKI)
genes, which are core regulators of a
eukaryotic cell-cycle signaling pathway
(Besson et al., 2008; Harashima et al.,
2013). A major function of CKIs is to
modulate the activities of cyclin-depen-
dent kinase (CDK) complexes, which
promote progression through the cell divi-
sion cycle. During cell-cycle pathway
activation, CDKs phosphorylate another
core cell-cycle regulator, Retinoblastoma
(RB). This promotes RB dissociation from
a set of E2F transcription factors that
become released for gene expression re-
programming (De Veylder et al., 2007;
Polager and Ginsberg, 2008).
Combined Arabidopsis loss-of-function
mutations in two other KRP-family genes,
SIAMESE (SIM) and SIAMESE-RELATED
1 (SMR1), strongly attenuate the cpr5
autoimmunity and developmental phe-
notypes. Therefore, SIM and SMR1 are
required for cpr5-induced immunity,
PCD, and abnormal development. Strik-
ingly, the sim smr1 mutants in a CPR5
wild-type background are also impaired
in ETI and ETI-associated PCD against
different NLR-recognized pathogenic
strains. Similarly, an Arabidopsis E2F
transcription factor triple signaling mutant708 Cell Host & Microbe 16, December 10, 20(e2fabc) exhibits reduced ETI and PCD,
although with different penetrance than
in the sim smr1 plants. Both types of
Arabidopsis cell-cycle mutant have a
less obvious effect on basal immunity
against a virulent pathogen, suggesting
that these core cell-cycle regulators might
be preferentially engaged for ETI. A com-
parison of gene expression profiles be-
tween the different mutant lines and with
published Arabidopsis expression data
established that there is a significant
overlap between the cpr5-induced SIM/
SMR1-dependent and E2F-driven tran-
scriptional defense programs. Together,
the data suggest a model in which NLR-
triggered resistance pathways converge
on core cell-cycle signaling components
to drive host immunity and cell death
outputs. In the model, CPR5 has a nega-
tive or constraining function at a point
downstream of the activated NLRs. A
resistance-limiting role of CPR5 is further
supported by the partial loss of ETI in
Arabidopsis CPR5-green fluorescent pro-
tein-overexpressing lines.
Having built a genetic framework inAra-
bidopsis, the authors explore the molecu-
lar processes underpinning recruitment
of Arabidopsis CPR5 and the canonical
CKI-CDK-RB-E2F cell-cycle regulators
in NLR-conditioned ETI. CPR5 resides at
the nuclear membrane where it interacts
with SIM. Interestingly, CPR5-SIM asso-
ciation is markedly reduced upon NLR
induction of ETI, suggesting that CPR5
negative regulation of SIM is disrupted
downstream of NLR-effector recognition,
potentially releasing SIM from the nuclear
rim to connect with CDK-cyclin com-
plexes. The precise functional relation-
ship between the Arabidopsis SIM/
SMR1 CKIs and CDKs in ETI is not clear
because CKIs can have both CDK-inhibi-
tory and stabilizing effects (Besson et al.,
2008). Mammalian CKI counterparts
bind to and modulate CDK phosphoryla-
tion of RB leading to E2F release to acti-
vate steps in cell-cycle progression.
There is also evidence that CKIs can
have a number of CDK-independent roles
in transcriptional reprogramming and pro-
motion of cell death, depending on the
cellular or stress context (De Veylder
et al., 2007; Besson et al., 2008). Notably,
Wang et al. (2014) show that Arabidopsis
RBR1, which is a conserved ortholog of
the mammalian CDK target, RB, is more
highly phosphorylated in a SIM/SMR1-14 ª2014 Elsevier Inc.dependent manner in both the cpr5
constitutive resistance mutant and after
pathogen elicitation of ETI. The same level
of RBR1 phosphorylation was not de-
tected in a nonrecognizing NLR mutant
or after inoculating plants with a virulent
pathogen to induce basal resistance.
Therefore, the phosphorylation status of
RBR1 and hence its power to activate
E2F-mediated transcriptional defense
outputs might be a key driver of ETI.
The authors propose that this resistance
circuit takes canonical cell-cycle com-
ponents out of their normal cell-cycle pro-
gression mode toward noncanonical
activities mediating ETI responses and
PCD. It will be interesting in future studies
tomeasure the RBR1 phosphorylation dy-
namics in ETI and basal resistance and
test whether RBR1 phosphorylation is
causal for mobilizing E2F transcription
relay and defense. Also, since NLRs can
be activated at different cell locations,
events connecting NLRs to the nuclear
cell-cycle and transcriptional machineries
need to be resolved. Here, a role for the
nuclear trafficking machinery and nucleo-
cytoplasmic coordination in ETI is well
supported (Maekawa et al., 2011).
Data presented in this paper are sig-
nificant in two further respects. First,
they highlight the importance of E2F tran-
scription factors in plant immunity. E2Fs
represent a versatile family of canonical
and noncanonical transcriptional regula-
tors that can interact with other trans-
cription factors and chromatin modifiers
to mediate cell-cycle progression, cell
death, and immunity outputs (De Veylder
et al., 2007; Polager and Ginsberg, 2008;
Chandran et al., 2014). Therefore, like
the CKIs, E2Fs are important integrators
of cellular homeostasis and stress. Sec-
ond, they suggest a mechanism by which
host PCD during ETI can be initiated in-
side nuclei, perhaps representing an
important checkpoint between basal de-
fense activation and cell survival or a
commitment to cell death. ETI-related
PCD pathways can proceed in different
parts of the cell (Maekawa et al., 2011),
so the events described here likely repre-
sent one of several avenues to cell death.
In mammals and plants, a variety of cell
death morphologies have been discov-
ered with different immunity outcomes
(Maekawa et al., 2011). Since PCD can
often be uncoupled from disease resis-
tance in ETI, this leaves open the
Cell Host & Microbe
Previewsimportant question of what actually stops
the pathogen from growing.
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